Chinese Children's Cancer Group-2025 Protocol for Newly Diagnosed for Intermediate/High Risk Childhood B-cell ALL
Latest Information Update: 13 Jan 2025
Price :
$35 *
At a glance
- Drugs Blinatumomab (Primary) ; Cyclophosphamide; Dexamethasone; Methotrexate; Venetoclax; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 13 Jan 2025 New trial record